Table 3: Correlates of the total of the two markers for hepatitis B and C co-infection in the study population.
| Factors |
Univariate analysis |
Multivariate analysis |
| OR (95% CI) |
P |
OR (95%CI) |
P |
| Age, ≥42years |
1.17(0.73-1.89) |
0.52 |
|
|
| Sex: Male |
1.43(0.83-2.46) |
0.19 |
|
|
| HIV infection, ≥5 years |
1.13(0.69-1.82) |
0.62 |
|
|
| ART duration, ≥5 years |
1.12(0.68-1.80) |
0.65 |
|
|
| WHO, stage 3&4 |
1.63(0.95-2.81) |
0.07 |
1.44(0.82-2.52) |
0.21 |
| CD4, ≥200cells/mm3 |
0.74(0.39- 1.40) |
0.36 |
|
|
| OIs, yes |
1.58(0.96-2.62) |
0.07 |
1.26(0.75-2.14) |
0.39 |
| Alcohol consumption, yes |
1.19(0.71-2.00) |
0.50 |
|
|
| Smoking, yes |
1.73(0.49-6.05) |
0.38 |
|
|
| Scarification, yes |
0.86(0.53-1.39) |
0.55 |
|
|
| Tattoo, yes |
0.99(0.35-2.87) |
0.99 |
|
|
| Piercing, yes |
0.64(0.23-1.82) |
0.40 |
|
|
| Blood transfusion, yes |
0.90(0.50-1.63) |
0.73 |
|
|
| Surgery, yes |
1.73(1.02-2.92) |
0.038 |
1.83(1.06-3.14) |
0.03 |
| Multiple sexual partners, yes |
1.77(1.03-3.03) |
0.036 |
1.46(0.80-2.69) |
0.22 |
| History of STIs, yes |
2.09(1.07-4.10) |
0.027 |
2.20(1.04-4.68) |
0.04 |
| History of liver disease, yes |
0.44(0.10-3.30) |
0.41 |
|
|
OI: opportunistic infection; STIs: sexually transmitted infections; ART: antiretroviral therapy; CD4: cluster of differentiation 4, OR: Odds ratio; CI: confidence interval.
Variables such as age, duration of HIV infection and treatment were categorized at their medians before being entered in univariable analysis and all variables that reached significance at the level of 10% in univariable analysis were entered by default in the final multivariable analysis.